Lyra therapeutics ipo date
Web1 mai 2024 · Lyra Therapeutics, a Phase 2 biotech developing an implantable drug-device for chronic rhinosinusitis, raised $56 million by offering 3.5 million shares at $16, the high … Web6 apr. 2024 · The Lyra Therapeutics Inc. stock price gained 4.91% on the last trading day (Thursday, 6th Apr 2024), rising from $2.24 to $2.35. During the last trading day the …
Lyra therapeutics ipo date
Did you know?
Web2 iun. 2024 · Lyra Therapeutics: Investor Contact: Argot Partners 212-600-1902 [email protected] Media Contact: Kathryn Morris 914-204-6412 … Web7 mar. 2024 · The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2024. Lyra Therapeutics, Inc. was …
Web21 apr. 2024 · Title: Impact of long-acting implantable corticosteroid matrices on SNOT-22 subdomains in CRS patients Date and Time: Thursday, April 28, 2024, at 9:32 – 9:40 … Web29 mar. 2024 · LYRA THERAPEUTICS, INC. Consolidated Balance Sheets (in thousands, except share and per share data) December 31, 2024 2024 Assets
Web9 mar. 2024 · Quick Take. Lyra Therapeutics (NASDAQ:LYRA) has filed to raise $57.5 million in an IPO of its common stock, according to an S-1 registration statement.The … http://ipoboutique.com/cgi/info/LyraTherapeutics-LYRA.php
WebTrade Date. Lyra Therapeutics, Inc. LYRA - NASDAQ. $14.00-$16.00: $16.00: $21.00: 3.5 million: 5/1/2024: ... About Lyra Therapeutics, Inc. (adapted from Lyra Therapeutics, …
Web10 mai 2024 · First Quarter 2024 Financial Highlights. Cash and cash equivalents as of March 31, 2024 were $33.8 million, compared with $45.7 million at December 31, 2024, … pet friendly hotels horsham paWebLyra Therapeutics is a clinical-stage company developing medicines precisely designed to target ear, nose and throat (ENT) diseases. Use the CB Insights Platform to explore Lyra … pet friendly hotels in albayWeb27 apr. 2024 · Lyra Therapeutics (LYRA) has filed to raise $52.5 million in gross proceeds in an IPO, per an amended registration statement. ... Expected IPO Pricing Date: April … star trek episode the arenaWeb27 apr. 2024 · Lyra Therapeutics aims to raise $52.5 million in an IPO of its common stock. The firm is advancing two drug candidates for the treatment of chronic rhinosinusitis. ... star trek familiar of zeroWebIPO Edge. Full Article 2 minutes read In the News Lyra Therapeutics Announces Pricing of Initial Public Offering. by IPO Edge. 3 years ago 2 minutes read Share on Facebook; … pet friendly hotels in alpena michiganWeb31 dec. 2024 · WATERTOWN, Mass., March 29, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage … pet friendly hotels in alwarWebLyra Therapeutics is a clinical-stage company developing medicines to treat ear, nose, and throat diseases. ... Post-IPO Equity - Lyra Therapeutics . 6: $100.5M — Jan 29, 2024: … pet friendly hotels in anguilla